<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01358396</url>
  </required_header>
  <id_info>
    <org_study_id>HB-DME-1</org_study_id>
    <nct_id>NCT01358396</nct_id>
  </id_info>
  <brief_title>Glycemic Control and Diabetic Macular Edema</brief_title>
  <official_title>The Effect of Glycemic Control on Visual and Anatomical Outcomes in Response to Therapy for Diabetic Macular Edema.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does diabetic patients' glycemic control affect their response to laser and/or intravitreal
      injection therapy in terms of visual and anatomical outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the visual and anatomical response to therapy in patients with diabetic macular
      edema (DME) in relation to their glycemic control.

      Patients with DME with central foveal thickness (CFT) &gt; 250µm with no proliferative disease
      had their glycosolated hemoglobin (HbA1c) measured at baseline and 3 months. CFT by optical
      coherence tomography, and best corrected visual acuity (BCVA) in logMARs were measured at
      baseline, 1, and 3 months. Exclusion criteria: laser or intravitreal injections within 6
      months, hard exudates within 500um of the foveal center, or macular traction. Therapy
      included laser and intravitreal anti VEGFs. HbA1c graded as: G1=&lt;7%, G2= 7-7.9%, G3= 8-8.9%,
      G4 = &gt;9%; and as: low &lt;8%, high ≥ 8%.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">July 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>3 months</time_frame>
    <description>Correlate baseline HBA1c to the visual outcomes.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">52</enrollment>
  <condition>Diabetic Macular Edema</condition>
  <arm_group>
    <arm_group_label>HBA1c</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Respond to therapy for diabetic macular edema</intervention_name>
    <description>Correlate HBA1c with visual acuity outcome to therapy.</description>
    <arm_group_label>HBA1c</arm_group_label>
    <other_name>Diabetic Macular Edema and Glycemic Control Using glycosylated hemoglobin</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Diabetic patients with macular edema with central foveal thickness more than 250 microns
        and no proliferative changes.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Central foveal thickness more than 250 microns

        Exclusion Criteria:

          -  Proliferative Diabetic Retinopathy.

          -  Traction Macular Membranes

          -  Previous Laser or intravitreal injections within 6 months.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11431</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2011</study_first_submitted>
  <study_first_submitted_qc>May 20, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2011</study_first_posted>
  <last_update_submitted>May 20, 2011</last_update_submitted>
  <last_update_submitted_qc>May 20, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2011</last_update_posted>
  <responsible_party>
    <name_title>Tamer A Macky</name_title>
    <organization>Cario University</organization>
  </responsible_party>
  <keyword>Diabetic Macular Edema, Glycemic Control</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
    <mesh_term>Macular Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

